When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.

That's why we have released our Free Precious Metals Investment Guide.

Charles W. Olson net worth and biography

Charles Olson Biography and Net Worth

VP of Surmodics

Charles W. Olson is Senior Vice President of Commercial and Business Development for the Medical Devices business unit. Charlie joined Surmodics in July 2001 as Market Development Manager, was named General Manager of Hydrophilic Technologies business unit in April 2004 and was promoted to Vice President and General Manager of Hydrophilic Technologies in October 2004. He added the responsibilities of Vice President of Sales in April 2005 and was promoted to Senior Vice President of Business Development and Marketing in March 2010. Charlie was promoted to Senior Vice President and General Manager of the Medical Device business unit in October 2010 and to his current role in August 2016. Before joining Surmodics, Charlie was employed as General Manager at Minnesota Extrusion and worked at Lake Region Manufacturing in project management and technical sales. Charlie received a BSBA degree in Marketing from Winona State University in 1987.

What is Charles W. Olson's net worth?: The estimated net worth of Charles W. Olson is at least $1.06 million as of April 28th, 2021. Mr. Olson owns 40,584 shares of Surmodics stock worth more than $1,058,025 as of April 25th. This net worth evaluation does not reflect any other assets that Mr. Olson may own. Additionally, Mr. Olson receives an annual salary of $618,470.00 as VP at Surmodics. Learn More about Charles W. Olson's net worth.
How old is Charles W. Olson?: Mr. Olson is currently 60 years old. There are 6 older executives and no younger executives at Surmodics. The oldest executive at Surmodics is Mr. Gary R. Maharaj, CEO, President & Director, who is 61 years old. Learn More on Charles W. Olson's age.
What is Charles W. Olson's salary?: As the VP of Surmodics, Inc., Mr. Olson earns $618,470.00 per year. There are 3 executives that earn more than Mr. Olson. The highest earning executive at Surmodics is Mr. Gary R. Maharaj, CEO, President & Director, who commands a salary of $1,330,000.00 per year. Learn More on Charles W. Olson's salary.
How do I contact Charles W. Olson?: The corporate mailing address for Mr. Olson and other Surmodics executives is 9924 WEST 74TH STREET, EDEN PRAIRIE MN, 55344. Surmodics can also be reached via phone at (952) 500-7000 and via email at [email protected]. Learn More on Charles W. Olson's contact information.
Has Charles W. Olson been buying or selling shares of Surmodics?: Charles W. Olson has not been actively trading shares of Surmodics during the last ninety days. Most recently, Charles W. Olson sold 1,292 shares of the business's stock in a transaction on Tuesday, August 31st. The shares were sold at an average price of $59.75, for a transaction totalling $77,197.00. Following the completion of the sale, the vice president now directly owns 39,292 shares of the company's stock, valued at $2,347,697. Learn More on Charles W. Olson's trading history.
Who are Surmodics' active insiders?: Surmodics' insider roster includes Jose Bedoya (Director), David Dantzker (Director), Gary Maharaj (CEO), John Manders (Insider), Charles Olson (VP), and Joseph Stich (SVP). Learn More on Surmodics' active insiders.

Charles W. Olson Insider Trading History at Surmodics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/31/2021	Sell	1,292	$59.75	$77,197.00	39,292
4/28/2021	Sell	1,508	$59.75	$90,103.00	40,584
4/16/2021	Sell	648	$59.75	$38,718.00	42,092
3/31/2021	Sell	4,759	$56.75	$270,073.25	42,740
6/11/2018	Sell	10,000	$55.00	$550,000.00	39,955
5/24/2018	Sell	20,000	$48.54	$970,800.00	33,467
9/15/2017	Sell	801	$27.85	$22,307.85	26,585
12/22/2016	Sell	1,201	$26.00	$31,226.00	27,386
12/8/2016	Sell	3,699	$26.02	$96,247.98	28,587
11/25/2016	Sell	500	$26.02	$13,010.00	27,245
8/17/2016	Sell	9,936	$28.98	$287,945.28	33,098
8/1/2016	Sell	12,500	$27.08	$338,500.00	35,531
12/29/2014	Sell	5,083	$21.98	$111,724.34
12/8/2014	Sell	3,365	$21.66	$72,885.90

Charles W. Olson Buying and Selling Activity at Surmodics

Surmodics Company Overview

Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for neurovascular, peripheral, coronary, and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

Today's Range

Now: $25.78

$25.22

$25.78

50 Day Range

MA: $29.00

$25.39

$33.26

2 Week Range

Now: $25.78

$16.79

$39.41

Volume

6,125 shs

Average Volume

57,983 shs

Market Capitalization

$367.11 million

P/E Ratio

67.84

Dividend Yield

N/A

Beta

1.01

The Gold Grab of the Century

From Colonial Metals | Ad